Form 4: Neogenomics Director Anthony P. Zook Reports Stock Transactions
SEC Form 4 Filing
Director Anthony P. Zook reports the release of restricted stock units and subsequent ownership of common stock in Neogenomics Inc.
Summary
- On August 10, 2024, Director Anthony P. Zook reported transactions involving Neogenomics Inc. (NEO) stock.
- The transactions involved the release of 11,336 restricted stock units, which converted into 11,336 shares of common stock.
- Following the transaction, Zook directly owns 11,336 shares of Neogenomics common stock.
- Zook also holds derivative securities, including stock options and restricted stock units, with varying exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, reporting stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the trading activities of company directors.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the stock transactions of a company director.
Key Dates
| Date | Description |
|---|---|
| 08/10/2024 | Date of transaction: release of restricted stock units and acquisition of common stock. |
| 08/10/2024 | Stock option (Right to Buy) Expiration Date |
| 06/01/2025 | Stock option (Right to Buy) Exercisable Date |
| 06/01/2025 | Restricted Stock Unit Exercisable Date |
| 06/01/2034 | Stock option (Right to Buy) Expiration Date |
| 08/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.